Drug intelligence / Profile preview

ALPHA JECT micro 2000

Development stage
Unknown
Lead developer
PHARMAQ
Modality
Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
Administration
Intraperitoneal
01

Overview

ALPHA JECT micro 2000 is an innovative, oil-based, inactivated bacterial vaccine developed for the prevention of vibriosis and pasteurellosis (photobacteriosis) in farmed sea bass. The vaccine contains inactivated Listonella anguillarum (serotype O1) and Photobacterium damsela subsp. piscicida as active components. It is administered via intraperitoneal injection, typically at a low dose of 0.05 ml per fish, allowing vaccination of smaller fish (minimum weight ~12 grams). The mechanism of action involves stimulating the immune system to produce specific antibodies against these pathogens, thereby increasing resistance to disease outbreaks during the farming cycle. The formulation uses a non-mineral oil adjuvant for gradual antigen release and long-lasting protection until harvest[6][1].

Brand names
ALPHA JECT micro 2000

Beyond the preview

Go deeper on ALPHA JECT micro 2000.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ALPHA JECT micro 2000.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call